• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Silent reintroduction of wild-type poliovirus to Israel, 2013 ? risk communication challenges in an argumentative atmosphere

Giuseppe

Emeritus
[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]


Eurosurveillance, Volume 19, Issue 7, 20 February 2014

Perspectives

Silent reintroduction of wild-type poliovirus to Israel, 2013 ? risk communication challenges in an argumentative atmosphere

E Kaliner <SUP>1</SUP>, J Moran-Gilad<SUP>1</SUP><SUP>,2</SUP>, I Grotto<SUP>1</SUP><SUP>,2</SUP>, E Somekh<SUP>3</SUP><SUP>,4</SUP>, E Kopel<SUP>1</SUP>, M Gdalevich<SUP>2</SUP><SUP>,5</SUP>, E Shimron<SUP>6</SUP>, Y Amikam<SUP>6</SUP>, A Leventhal<SUP>6</SUP>, B Lev<SUP>6</SUP>, R Gamzu<SUP>4</SUP><SUP>,6</SUP>
<SUP></SUP>
1Public Health Services, Ministry of Health, Jerusalem, Israel - 2 Faculty for Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel - 3 Paediatric Infectious Diseases, Wolfson Medical Center, Holon, Israel - 4 Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel - 5 South District Health Office, Ministry of Health, Beer Sheva, Israel - 6 Ministry of Health, Jerusalem, Israel
_____

Citation style for this article: Kaliner E, Moran-Gilad J, Grotto I, Somekh E, Kopel E, Gdalevich M, Shimron E, Amikam Y, Leventhal A, Lev B, Gamzu R. Silent reintroduction of wild-type poliovirus to Israel, 2013 ? risk communication challenges in an argumentative atmosphere . Euro Surveill. 2014;19(7):pii=20703. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20703
Date of submission: 01 October 2013

______

Israel has been certified as polio-free by the World Health Organization and its routine immunisation schedule consists of inactivated poliovirus vaccine (IPV) only. At the end of May 2013, the Israeli Ministry of Health (MOH) has confirmed the reintroduction of wild-type poliovirus 1 into the country. Documented ongoing human-to-human transmission necessitated a thorough risk assessment followed by a supplemental immunisation campaign using oral polio vaccine (OPV). The unusual situation in which ongoing poliovirus transmission was picked up through an early warning system of sewage monitoring without active polio cases, brought about significant challenges in risk communication. This paper reviews the challenges faced by the MOH and the communication strategy devised, in order to facilitate and optimise the various components of the public health response, particularly vaccination. Lessons learned from our recent experience may inform risk communication approaches in other countries that may face a similar situation as global polio eradication moves towards the 'End game'.


-
-------
 
Back
Top Bottom